Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection

Translational Research

Volumn 162, Issue 4, 2013, Pages 258-268

  Tsai, Hsiang Lin ^a   Yang, I Ping ^a   Huang, Ching Wen ^a   Ma, Cheng Jen ^a   Kuo, Chao Hung ^a   Lu, Chien Yu ^a   Juo, Suh Hang ^a   Wang, Jaw Yuan ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 148; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; RELAPSE; TUMOR INVASION; VALIDATION STUDY; XENOGRAFT;

EID: 84884552643     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.07.009     Document Type: Article

References (45)

1. M.A. Pourhoseingholi Increased burden of colorectal cancer in Asia World J Gastrointest Oncol 4 2012 68 70
2. K.G. Yeoh, K.Y. Ho, and H.M. Chiu The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects Gut 60 2011 1236 1241
3. Department of Health, Executive Yuan, Taiwan, Available at: www.doh.gov.tw/statistic/index.htm. Accessed February 2013.
4. S.B. Edqe, and C.C. Compton The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Am Surg Oncol 17 2010 1471 1474
5. I.P. Yang, H.L. Tsai, and M.F. Hou MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle Carcinogenesis 33 2012 1522 1530
6. H. Kobayashi, H. Mochizuki, and K. Suqihara Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study Surgery 141 2007 67 75
7. A.J. Vickers, F.J. Bianco Jr., S. Boorjian, P.T. Scardino, and J.A. Eastham Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence? Cancer 106 2006 576 580
8. W.C. Cho MicroRNAs in cancer: from research to therapy Biochem Biophys Acta 1805 2010 209 217
9. W.C. Cho MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy Int J Biochem Cell Biol 42 2010 1273 1281
10. J. Weitz, M. Koch, J. Debus, T. Hohler, P.R. Galle, and M.W. Buchler Colorectal cancer Lancet 365 2005 153 165
11. A.L. Gartel, and E.S. Kandel miRNAs: little known mediators of oncogenesis Semin Cancer Biol 18 2008 103 110
12. Y. Ma, P. Zhang, J. Yang, Z. Liu, Z. Yang, and H. Qin Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation Int J Cancer 130 2012 2077 2087
13. X. Luo, B. Burwinkel, S. Tao, and H. Brenner MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev 20 2011 1272 1286
14. D. Saha, C. Roman, and D. Beauchamp New strategies for colorectal cancer prevention and treatment World J Surg 26 2002 762 766
15. C.J. Allergra, S. Paik, and L.H. Colangelo Prognostic value of thymidylate synthase, ki-67, and p53 in patients with Dukes' B and C colon cancer: A National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study J Clin Oncol 21 2003 241 250
16. kip-1 Int J Cancer 97 2002 403 409
17. A.J. Schetter, S.Y. Leung, and J.J. Sohn MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma JAMA 299 2008 425 436
18. D.D. Taylor, and C. Gercel-Taylor MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol Oncol 110 2008 13 21
19. G. Rabinowits, C. Gercel-Taylor, J.M. Day, D.D. Taylor, and G.H. Kloecker Exosomal microRNA: a diagnostic marker for lung cancer Clin Lung Cancer 10 2009 42 46
20. T. Andrey, W. Ludmila, and B. Barbara Extracellular miRNAs: the mystery of their origin and function Trend Biochem Sci 37 2012 460 465
21. W.E. Longo, and F.E. Johnson The preoperative assessment and postoperative surveillance of patients with colon and cancer Surg Clin North Am 85 2002 1091 1108
22. H.L. Tsai, K.S. Chu, and Y.H. Huang Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection J Surg Oncol 100 2009 736 743
23. C.C. Hwang, H.T. Chai, and H.W. Chen S100B protein expressions as an independent predictor of early relapse in UICC stage II and III colon cancer patients after curative resection Am Surg Oncol 18 2011 139 145
24. K.H. Chang, P. Mestdagh, J. Vandesompele, M.J. Kerin, and N. Miller MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer BMC Cancer 10 2010 173
25. T.J. Wu, C.N. Yeh, T.C. Chao, Y.Y. Jan, and M.F. Chen Prognostic factors of primary small bowel adenocarcinoma univariate and multivariate analysis World J Surg 30 2006 391 398
26. P. Burfeinf, C.L. Chernicky, F. Rinisland, and J. Ilan Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo Proc Natl Acad Sci USA 93 1996 7263 7268
27. H.L. Tsai, I.P. Yang, and C.H. Lin Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection Int J Colorectal Dis 28 2013 415 424
28. M. Buyse, and P. Piedbois Should Dukes' B patients receive adjuvant therapy? A statistical perspective Semin Oncol 28 2001 20 24
29. A. Esquela-Kerscher, and F.J. Slack Oncomirs-microRNAs with a role in cancer Nat Rev Cancer 6 2006 259 269
30. G.A. Calin, M. Ferracin, and A. Cimmino A microRNA signature associated with prognosis and progression in chronic lymphcytic leukemia N Eng J Med 353 2005 1793 1801
31. B. Xiao, J. Guo, and Y. Miao Detection of miR-106a in gastric carcinoma and its clinical significance Clin Chem Acta 400 2009 97 102
32. O. Slaby, M. Svoboda, and P. Fabian Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer Oncology 72 2007 397 402
33. R.Q. Liang, W. Li, and Y. Li An oligonucleotide microarray for microRNA expression analysis based on labeling RNA with quantum dot and nanogold probe Nucl Acids Res 33 2005 e17
34. J. Lu, G. Getz, and E.A. Miska MicroRNA expression profiles classify human cancer Nature 435 2006 834 838
35. R. Shi, and V.L. Chiang Facile means for quantifying microRNA expression by real-time PCR Biotechniques 39 2005 519 525
36. Y. Chen, Y. Song, and Z. Wang Altered expression of miR-148a and miR-152 in gastrointestinal cancers and its clinical significance J Gastrointest Surg 14 2010 1170 1179
37. A. Lujambio, G.A. Calin, and A. Villanueva MicroRNA DNA methylation signature for human cancer metastasis Pro Natl Acad Sci USA 105 2008 13556 13561
38. N. Hanoun, Y. Delpu, and A.A. Suriawinata The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis Clin Chem 56 2010 1107 1118
39. U. Lehmann, B. Hasemeier, and M. Christgen Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer J Pathol 214 2008 17 24
40. S.T. Liffers, J.B. Munding, and M. Vogt MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinoma and regulates cell survival by targeting CDC 25B Lab Invest 91 2011 1472 1479
41. A. Lindquist, H. Kallstrom, A. Lundgren, E. Barsoum, and C.K. Rosenthal CDC 25B cooperates with CDC 25A to induce mitosis but has a unique role in activating cyclin B1-Cdk 1 at the centrosome J Cell Biol 171 2005 35 45
42. X. Tian, S. Song, J. Wu, L. Meng, Z. Dong, and C. Shou Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803 Biochem Biophys Res Commun 286 2001 505 512
43. Q. Xu, Y. Jiang, and Y. Yin A regulatory circuit of miR-148a/152 and DNMT 1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS-1 J Mol Cell Biol 1 2013 3 13
44. M. Takahashi, M. Cutrecasas, and F. Balaguer The clinical significance of miR-148a as a predictive biomarker in patients with advanced colorectal cancer PLoS One 7 2012 e46684
45. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng, and X. Du Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer Int J Cancer 127 2012 118 126